Cwm LLC has recently acquired shares of ARK Genomic Revolution ETF (BATS:ARKG). This move indicates a growing interest in the genomic revolution industry. ARKG focuses on companies that are at the forefront of genomic research and development, making it an attractive investment for those looking to capitalize on this rapidly evolving sector. With Cwm LLC acquiring shares of ARKG, it shows their confidence in the potential growth and innovation within the genomic revolution space. This acquisition highlights the increasing importance of genomics in the investment world and the potential for significant returns in this sector.